Testing Choices: From the standard to the extraordinary
Test | Test Name |
---|---|
0960B | Cannabinoids Panel, Blood |
0960FL | Cannabinoids Panel, Fluid |
0960ME | Cannabinoids Panel (Qualitative), Meconium |
0960SP | Cannabinoids Panel, Serum/Plasma |
0960TI | Cannabinoids Panel, Tissue |
0962B | Cannabidiol, Blood |
0962SP | Cannabidiol, Serum/Plasma |
0964U | Cannabinoid Metabolite, Urine |
0966B | Cannabis Plus Recent Use Markers, Blood |
0966SP | Cannabis Plus Recent Use Markers, Serum/Plasma |
0985B | Carbinoxamine, Blood |
1029SP | CBD, Serum/Plasma |
1040B | Cetirizine, Blood |
1040SP | Cetirizine, Serum/Plasma |
1040U | Cetirizine, Urine |
1190B | Chlorpheniramine, Blood |
1190SP | Chlorpheniramine, Serum/Plasma |
1190U | Chlorpheniramine, Urine |
1425B | Cyproheptadine, Blood |
1425SP | Cyproheptadine, Serum/Plasma |
1425U | Cyproheptadine, Urine |
9145UC | Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |